Detection of Vi-negative Salmonella enterica serovar Typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan

被引:57
作者
Baker, S
Sarwar, Y
Aziz, H
Haque, A
Ali, A
Dougan, G
Wain, J
Haque, A
机构
[1] Wellcome Trust Sanger Inst, Microbial Pathogenesis, Cambridge CB10 1SA, England
[2] Natl Inst Biotechnol & Genet Engn, Hlth Biotechnol Div, Faisalabad, Pakistan
关键词
D O I
10.1128/JCM.43.9.4418-4425.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The synthesis and transportation proteins of the Vi capsular polysaccharide of Salmonella enterica serovar Typhi (serovar Typhi) are encoded by the viaB operon, which resides on a 134-kb pathogenicity island known as SPI-7. In recent years, Vi-negative strains of serovar Typhi have been reported in regions where typhoid fever is endemic. However, because Vi negativity can arise during in vitro passage, the clinical significance of Vi-negative serovar Typhi is not clear. To investigate the loss of Vi expression at the genetic level, 60 stored strains of serovar Typhi from the Faisalabad region of Pakistan were analyzed by PCR for the presence of SPI-7 and two genes essential for Vi production: MA and tviB. Nine of the sixty strains analyzed (15%) tested negative for both MA and tviB; only two of these strains lacked SPI-7. In order to investigate whether this phenomenon occurred in vivo, blood samples from patients with the clinical symptoms of typhoid fever were also investigated. Of 48 blood samples tested, 42 tested positive by fliC PCR for serovar Typhi; 4 of these were negative for MA and tviB. Three of these samples tested positive for SPI-7. These results demonstrate that viaB-negative, SPI-7-positive serovar Typhi is naturally occurring and can be detected by PCR in the peripheral blood of typhoid patients in this region. The method described here can be used to monitor the incidence of Vi-negative serovar Typhi in regions where the Vi vaccine is used.
引用
收藏
页码:4418 / 4425
页数:8
相关论文
共 45 条
[1]   Urgent need for effective vaccine against Salmonella paratyphi A, B and C [J].
Arya, SC ;
Sharma, KB .
VACCINE, 1995, 13 (17) :1727-1728
[2]  
Arya SC, 2000, NATL MED J INDIA, V13, P220
[3]  
Bäumler AJ, 1998, INFECT IMMUN, V66, P4579
[4]   The record of horizontal gene transfer in Salmonella [J].
Baumler, AJ .
TRENDS IN MICROBIOLOGY, 1997, 5 (08) :318-322
[5]   Precise excision of the large pathogenicity island, SP17, in Salmonella enterica serovar Typhi [J].
Bueno, SM ;
Santiviago, CA ;
Murillo, AA ;
Fuentes, JA ;
Trombert, AN ;
Rodas, PI ;
Youderian, P ;
Mora, GC .
JOURNAL OF BACTERIOLOGY, 2004, 186 (10) :3202-3213
[6]   Genomic comparison of Salmonella enterica serovars and Salmonella bongori by use of an S-enterica serovar Typhimurium DNA microarray [J].
Chan, K ;
Baker, S ;
Kim, CC ;
Detweiler, CS ;
Dougan, G ;
Falkow, S .
JOURNAL OF BACTERIOLOGY, 2003, 185 (02) :553-563
[7]  
Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346
[8]  
EWING WH, 1986, EDWRADS EWINGS IDENT
[9]   UNIQUE SEQUENCES IN REGION-VI OF THE FLAGELLIN GENE OF SALMONELLA-TYPHI [J].
FRANKEL, G ;
NEWTON, SMC ;
SCHOOLNIK, GK ;
STOCKER, BAD .
MOLECULAR MICROBIOLOGY, 1989, 3 (10) :1379-1383
[10]   Pathogenicity islands and the evolution of microbes [J].
Hacker, J ;
Kaper, JB .
ANNUAL REVIEW OF MICROBIOLOGY, 2000, 54 :641-679